ADVFN US – Market Content Editor
-
U.S. Employment Increased More Than Expected In September
A long-overdue U.S. labor market update released Thursday revealed that hiring in September was far stronger than economists had anticipated. According to the Labor Department, nonfarm payrolls rose by 119,000 positions during the month, easily outpacing expectations and reversing a previously revised decline of 4,000 jobs in August. Forecasters had been looking for a more…
-
Dow Jones, S&P, Nasdaq, Futures, Upbeat Nvidia Results Set the Stage for an Early Wall Street Rally
U.S. stock futures point to a sharply higher open on Thursday, signaling that equities may extend the momentum built in the prior session. The renewed strength comes as investors enthusiastically respond to long-awaited quarterly results from market heavyweight and AI standard-bearer Nvidia (NASDAQ:NVDA). Nvidia shares are up 5.1 percent in premarket trade after the chipmaker…
-
Meta Ordered to Pay €479 Million to Spanish Media Groups in GDPR Case
A Spanish court has directed Meta (NASDAQ:META) to pay €479 million to a group of 87 digital publishers and news agencies, according to an official court statement released Wednesday. The judge concluded that Meta obtained a “significant competitive advantage” by serving targeted advertising on Facebook and Instagram in a manner that violated the EU’s General…
-
Nvidia Shares Jump 5% Premarket as Analysts Brush Off AI Bubble Worries
Nvidia stock surged in early U.S. trading on Thursday after the chipmaker delivered another round of blockbuster results and an upbeat outlook, easing fears that the AI boom is overheating. Shares of NVIDIA Corporation (NASDAQ:NVDA) were up 4.9% by 05:42 ET (10:42 GMT), supported by strong fiscal third-quarter numbers and confident commentary from CEO Jensen…
-
Novartis Expects 5–6% Annual Sales Growth Through 2030
Novartis (NYSE:NVS) said Wednesday that it anticipates annual sales to expand by 5–6% through 2030, supported by a pipeline of eight major therapies each carrying peak revenue potential of between $3 billion and $10 billion. The Swiss pharmaceutical group updated its mid-term outlook by extending guidance to cover 2025–2030, projecting a compound annual growth rate…
-
Vipshop Tops Q3 Estimates, but Shares Slip as Investors Weigh Softer Outlook
Vipshop Holdings Limited (NYSE:VIPS) delivered third-quarter earnings and revenue that exceeded expectations on Thursday, yet its shares edged 1.48% lower in premarket trade as the market reacted cautiously to the company’s forward guidance. The Chinese online discount retailer reported adjusted earnings of RMB2.98 ($0.42) per ADS, modestly outperforming the consensus estimate of RMB2.91. Revenue rose…
-
VNET Shares Jump Nearly 6% After Q3 Revenue Tops Expectations Despite EPS Miss
VNET Group, Inc. (NASDAQ:VNET) saw its shares climb 5.77% in premarket trading Thursday after the Chinese data-center operator posted stronger-than-expected third-quarter revenue, even as it delivered a wider-than-anticipated loss. For the quarter ending September 30, 2025, VNET generated RMB2.58 billion ($362.7 million) in revenue, ahead of the RMB2.4 billion analyst consensus and marking a robust…
-
NetEase Shares Slip 3% After Q3 Revenue Falls Short of Forecasts
NetEase, Inc. (NASDAQ:NTES) traded lower in premarket action on Thursday after the company delivered quarterly earnings that exceeded expectations but reported revenue that missed analyst estimates. For the third quarter ending September 30, the Chinese gaming and internet group generated RMB28.4 billion ($4.0 billion) in revenue, up 8.2% year over year but below the RMB29.01…
-
Palo Alto Networks Shares Slip Despite Q1 Beat as Revenue Guidance Disappoints
Palo Alto Networks (NASDAQ:PANW) traded more than 4% lower in premarket action on Thursday after the cybersecurity leader posted stronger-than-expected quarterly results but paired them with a revenue outlook that failed to excite Wall Street. For its fiscal first quarter, the California-based group delivered adjusted earnings of $0.93 per share, topping the $0.89 consensus estimate.…
-
Valneva Falls Short of Revenue Expectations but Maintains Outlook; Shares Rise
Valneva (NASDAQ:VALN) posted nine-month revenues that came in below market forecasts, though the vaccine developer reaffirmed its full-year guidance, sending its shares up 6% in Paris following the announcement. The company reported total nine-month revenue of €127 million and product sales of €119.4 million, missing the €132.3 million consensus estimate cited by Kepler Cheuvreux. Ixiaro,…